Reviva Pharmaceuticals Holdings Inc.
RVPH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.59M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.59 Million |
|---|---|
| Enterprise Value | $-19,745,862,411,368.00 |
| Earnings per Share | $-5.48 |
| Beta | 0.48 |
| Outstanding Shares | 13,209,000 |
Return
| Return on Equity | -146.72% |
|---|---|
| Return on Assets | -105.54% |
| Return on Invested Capital | -150.04% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.48
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.29
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 5.08% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.06%▼ 52.37% |
|---|---|
| Total Invested | $3,673▼ 99.86% |
| Investors Holding | 5▼ 32.00% |
About Reviva Pharmaceuticals Holdings Inc.
5 employees
Reviva Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva's primary ...